Starz Entertainment signs new contract with CFO Scott Macdonald
Starz Entertainment Corp. has extended CFO Scott Macdonald's contract through 2028, emphasizing stability in leadership in a competitive industry.
TriLinc Global Impact Fund reports $283 million portfolio update
TriLinc Global Impact Fund LLC shares a portfolio update revealing $283 million in assets and significant repayments, impacting the finance services sector.
XBiotech appoints Co-CEOs in leadership transition
XBiotech Inc. announces Dr. Sushma Shivaswamy and Jan-Paul Simard as Co-CEOs, marking a pivotal leadership change in the pharmaceutical industry.
Perspective Therapeutics announces clinical trial results update
Perspective Therapeutics shares updated interim results from its clinical trial for a new treatment targeting neuroendocrine tumors, presented at a major congress.
Howard Hughes Holdings announces departure of CFO Elena Verbinskaya
Howard Hughes Holdings Inc. reveals the departure of Chief Accounting Officer Elena Verbinskaya, effective March 5, 2027, ensuring a smooth transition.
Freshpet appoints Nicola Baty as President with new pay plan
Freshpet, Inc. has appointed Nicola Baty as President, enhancing her compensation package as part of the company's leadership strategy.
Andersons, Inc. Restructures HR, Terminates Executive
Andersons, Inc. announces the termination of HR Executive Sarah J. Zibbel as part of a departmental restructuring, signaling operational changes.
Dole plc announces retirement of Non-Executive Director
Dole plc reveals the retirement of Non-Executive Director Helen Nolan, effective December 31, 2026, emphasizing governance in agricultural production.
Hormel Foods board member Sally J. Smith to retire
Sally J. Smith announces her retirement from Hormel Foods' board ahead of the 2027 Annual Meeting, marking a significant leadership change.
Mercedes-Benz Auto Lease Trust issues $1.32 billion in notes
Mercedes-Benz Auto Lease Trust 2026-B announces $1.32 billion in asset-backed notes to enhance financing capabilities in the competitive auto leasing market.
United States Antimony Corp. Releases New Technical Report
United States Antimony Corp. announces completion of a technical report on its Nolan Creek Property, enhancing resource assessment capabilities.
Atmus Filtration Technologies announces executive resignation
Atmus Filtration Technologies Inc. announces the resignation of its Chief People Officer, effective November 11, 2026, with an interim replacement named.
Onconetix advances $500,000 to Realbotix, total hits $3M
Onconetix, Inc. has advanced an additional $500,000 to Realbotix, increasing the total loan amount to $3 million, signaling continued financial support.
ArriVent BioPharma Reveals Initial Phase 1 Data for ARR-217
ArriVent BioPharma announces promising Phase 1 data for ARR-217, a potential treatment for gastrointestinal cancers, at ESMO Congress 2026.
Eikon Therapeutics reports promising EIK1001 trial results
Eikon Therapeutics announces positive results from its EIK1001 trial for lung cancer, presented at the ESMO Congress, impacting the biological products sector.
Phathom Pharmaceuticals faces lawsuit over VOQUEZNA exclusivity
Phathom Pharmaceuticals is challenged by BDR Pharmaceuticals in a lawsuit regarding FDA exclusivity for its drug VOQUEZNA, potentially impacting its market position.
GridAI Technologies Corp. board member resigns effective Oct. 19
GridAI Technologies Corp. announces the resignation of board member Manpreet Uppal, effective October 19, 2026, with no disagreements noted.
Bank of America announces executive leadership changes
Bank of America Corp reveals key executive changes, signaling a potential shift in strategy amid evolving industry challenges.
Civista Bancshares declares quarterly dividend of 18 cents
Civista Bancshares, Inc. announces a quarterly dividend of 18 cents per share, maintaining its previous rate and reflecting its commitment to shareholders.
Kustom Entertainment increases authorized shares to 1.2 billion
Kustom Entertainment, Inc. raises its authorized shares from 11.3 million to 1.2 billion to enhance capital-raising capabilities.